NR546 NR 546 MIDTERM FINAL
EXAM 2026 FINAL PAPER PRACTICE
QUESTIONS ANSWERS ACCURATE
A+
◉ Bipolar disorder treatment.
Answer: Combine antidepressants with mood stabilizers.
◉ SNRI breastfeeding caution.
Answer: Monitor infant irritability when prescribing SNRIs.
◉ Antidepressant prescribing factors.
Answer: Consider client preference, comorbidities, and interactions.
◉ Initial antidepressant dosing.
Answer: Start at lowest dose for 4-8 weeks.
◉ Citalopram dosage for elderly.
Answer: Reduce dose to half for older patients.
◉ Paroxetine contraindication.
Answer: Avoid in patients with history of falls.
,◉ SSRI screening requirements.
Answer: Check blood pressure before and during SNRI treatment.
◉ SSRI suicide risk age group.
Answer: Kids and adults under 25 are at higher risk.
◉ Escitalopram interactions.
Answer: Has the least CYP interactions among SSRIs.
◉ Fluoxetine half-life.
Answer: Longest acting with a half-life of 1-2 weeks.
◉ Discontinuation syndrome.
Answer: More likely with paroxetine after stopping.
◉ Sertraline safety.
Answer: Safe for use in nursing and pregnancy.
◉ Paroxetine pregnancy risk.
Answer: Contraindicated due to atrial septal defect risk.
◉ Adjunct medications.
Answer: Bupropion and mirtazapine have lowest sexual side effects.
, ◉ Serotonin syndrome.
Answer: Occurs with two serotonergic drugs; causes agitation.
◉ Serotonin syndrome symptoms.
Answer: Includes mental status changes and autonomic instability.
◉ MAOIs black box warning.
Answer: Suicidal ideation risk in youth.
◉ MAOI half-life.
Answer: Typically ranges from 2-4 hours.
◉ SSRIs black box warning.
Answer: Indicates risk of suicidal tendencies.
◉ MAOIs function.
Answer: Inhibit enzyme that deactivates neurotransmitters.
◉ MAOI side effects.
Answer: Include anticholinergic effects and weight gain.
◉ Hypertensive crisis risk.
EXAM 2026 FINAL PAPER PRACTICE
QUESTIONS ANSWERS ACCURATE
A+
◉ Bipolar disorder treatment.
Answer: Combine antidepressants with mood stabilizers.
◉ SNRI breastfeeding caution.
Answer: Monitor infant irritability when prescribing SNRIs.
◉ Antidepressant prescribing factors.
Answer: Consider client preference, comorbidities, and interactions.
◉ Initial antidepressant dosing.
Answer: Start at lowest dose for 4-8 weeks.
◉ Citalopram dosage for elderly.
Answer: Reduce dose to half for older patients.
◉ Paroxetine contraindication.
Answer: Avoid in patients with history of falls.
,◉ SSRI screening requirements.
Answer: Check blood pressure before and during SNRI treatment.
◉ SSRI suicide risk age group.
Answer: Kids and adults under 25 are at higher risk.
◉ Escitalopram interactions.
Answer: Has the least CYP interactions among SSRIs.
◉ Fluoxetine half-life.
Answer: Longest acting with a half-life of 1-2 weeks.
◉ Discontinuation syndrome.
Answer: More likely with paroxetine after stopping.
◉ Sertraline safety.
Answer: Safe for use in nursing and pregnancy.
◉ Paroxetine pregnancy risk.
Answer: Contraindicated due to atrial septal defect risk.
◉ Adjunct medications.
Answer: Bupropion and mirtazapine have lowest sexual side effects.
, ◉ Serotonin syndrome.
Answer: Occurs with two serotonergic drugs; causes agitation.
◉ Serotonin syndrome symptoms.
Answer: Includes mental status changes and autonomic instability.
◉ MAOIs black box warning.
Answer: Suicidal ideation risk in youth.
◉ MAOI half-life.
Answer: Typically ranges from 2-4 hours.
◉ SSRIs black box warning.
Answer: Indicates risk of suicidal tendencies.
◉ MAOIs function.
Answer: Inhibit enzyme that deactivates neurotransmitters.
◉ MAOI side effects.
Answer: Include anticholinergic effects and weight gain.
◉ Hypertensive crisis risk.
